These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2212143)

  • 21. Eosinophilia-myalgia syndrome associated with L-tryptophan use.
    Montanaro A; Wakefield D
    Med J Aust; 1990 Oct; 153(8):491-3. PubMed ID: 2215340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. L-tryptophan-associated eosinophilic fasciitis prior to the 1989 eosinophilia-myalgia syndrome outbreak.
    Hibbs JR; Mittleman B; Hill P; Medsger TA
    Arthritis Rheum; 1992 Mar; 35(3):299-303. PubMed ID: 1536667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scleroderma-like fasciitis without eosinophilia after L-tryptophan ingestion.
    Schlessel K; Greenwald R; Hirschfield L
    J Rheumatol; 1991 May; 18(5):779-82. PubMed ID: 1865433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan use.
    Varga J; Griffin R; Newman JH; Jimenez SA
    J Rheumatol; 1991 Feb; 18(2):259-63. PubMed ID: 2023221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuromuscular manifestations of L-tryptophan-associated eosinophilia-myalgia syndrome: a histomorphologic analysis of 14 patients.
    Verity MA; Bulpitt KJ; Paulus HE
    Hum Pathol; 1991 Jan; 22(1):3-11. PubMed ID: 1985074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic and L-tryptophan-associated eosinophilic fasciitis before and after L-tryptophan contamination.
    Blauvelt A; Falanga V
    Arch Dermatol; 1991 Aug; 127(8):1159-66. PubMed ID: 1863073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eosinophilic myositis an expression of L-tryptophan toxicity?
    Estrada CA; Harrington DW; Glasberg MR
    J Rheumatol; 1990 Nov; 17(11):1554-6. PubMed ID: 2273502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutaneous and subcutaneous inflammatory sclerosis syndromes.
    Doyle JA; Connolly SM; Winkelmann RK
    Arch Dermatol; 1982 Nov; 118(11):886-90. PubMed ID: 7138043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome.
    Gordon ML; Lebwohl MG; Phelps RG; Cohen SR; Fleischmajer R
    Arch Dermatol; 1991 Feb; 127(2):217-20. PubMed ID: 1990986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eosinophilia-myalgia syndrome.
    Troy JL
    Mayo Clin Proc; 1991 May; 66(5):535-8. PubMed ID: 2030620
    [No Abstract]   [Full Text] [Related]  

  • 31. The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology.
    Martin RW; Duffy J; Engel AG; Lie JT; Bowles CA; Moyer TP; Gleich GJ
    Ann Intern Med; 1990 Jul; 113(2):124-34. PubMed ID: 2360751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myalgia-hypereosinophilia syndrome caused by L-tryptophan].
    Lacour JP; Ortonne JP
    Ann Dermatol Venereol; 1990; 117(12):991-8. PubMed ID: 1964544
    [No Abstract]   [Full Text] [Related]  

  • 33. Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan: muscle biopsy findings in 4 patients.
    Hollander D; Adelman LS
    Neurology; 1991 Feb; 41(2 ( Pt 1)):319-21. PubMed ID: 1992385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tryptophan-associated eosinophilic connective-tissue disease. A new clinical entity?
    Clauw DJ; Nashel DJ; Umhau A; Katz P
    JAMA; 1990 Mar; 263(11):1502-6. PubMed ID: 2308182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophilia/myalgia syndrome associated with L-tryptophan.
    Lancet; 1990 Feb; 335(8685):353-5. PubMed ID: 1967787
    [No Abstract]   [Full Text] [Related]  

  • 36. An eosinophilia-myalgia syndrome associated with an L-tryptophan containing product.
    Saag KG; Goldschmidt R; Vernof H; Golbus J
    J Rheumatol; 1990 Nov; 17(11):1551-3. PubMed ID: 2273501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Eosinophilia-myalgia syndrome following administration of a L-tryptophan preparation].
    Frick P; Frey R
    Schweiz Med Wochenschr; 1990 Nov; 120(44):1633-5. PubMed ID: 2251478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.
    Crofford LJ; Rader JI; Dalakas MC; Hill RH; Page SW; Needham LL; Brady LS; Heyes MP; Wilder RL; Gold PW
    J Clin Invest; 1990 Nov; 86(5):1757-63. PubMed ID: 2243145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible scleroderma, fasciitis and perimyositis.
    Bondeson J; Rausing A
    Clin Exp Rheumatol; 1994; 12(1):71-3. PubMed ID: 8162647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The tryptophan-associated eosinophilia-myalgia syndrome. A clinical follow-up of 8 patients].
    Szeimies RM; Meurer M
    Dtsch Med Wochenschr; 1993 Feb; 118(7):213-20. PubMed ID: 8440161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.